Väljaminev kiriAvalik
Euroopa farmakopöa monograafia asjus
Ravimiamet · 14. mai 2025
- Viit
- REP-1/2475-2
- Registreeritud
- 14. mai 2025
- Dokumendi liik
- Väljaminev kiri
- Adressaat
- European Directorate for the Quality of Medicines & HealthCare
- Funktsioon
- REP Euroopa Farmakopöaga seotud asjaajamine
- Sari
- REP-1 Euroopa Farmakopöa alane kirjavahetus
- Toimik
- REP-1/2025
- Vastutaja
- Signe Leito (RA, Peadirektori asetäitja valdkond, Labor)
Sisu (failidest)
Survey for information of Group 10A on approved products containing
difloxacin hydrochloride trihydrate for veterinary use, as well as other forms
of difloxacin
page 1 / 4
Q1-4 (4194)
NPA: (53558)
Type: (!/list-dropdown)
A10 - Estonia (EE)
Is difloxacin hydrochloride trihydrate used in approved medicinal products (for veterinary or
human use) in your country?
(53559)
Type: (L/list-radio)
No
AO02
page 2 / 4
If yes, please list the names of the approved products and the contact details of any
corresponding MAHs or information on substance manufacturers. (53560)
Type: (T/text-long)
-
Are forms of difloxacin other than difloxacin hydrochloride trihydrate used in approved
medicinal products (for veterinary or human use) in your country? (53580)
Type: (L/list-radio)
No
AO02
If yes, please list the names of any approved products in your country that contain other forms of
difloxacin and the contact details of any corresponding MAHs or information on substance
manufacturers.
(53561)
Type: (T/text-long)
-
page 3 / 4
Does your country have any open-access online databases for approved veterinary medicinal
products? (53581)
Type: (L/list-radio)
Yes
AO01
If yes, we would be grateful if you could share with us links to any available databases.
(53582)
Type: (T/text-long)
https://www.ravimiregister.ee/en/PublicHomePage.aspx
Comments:
(53562)
Type: (T/text-long)
page 4 / 4